Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 14/20 | 0.47 |
| ▸ | CCKAR | P32238 | 5/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | OXTR | P30559 | 1/20 | 0.42 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2687501 | 1.00 | CCKBR (0.47) | CCKBRCCKARTRPA1OXTRBDKRB1 | |
| SCHEMBL30467339 | 0.91 | CCKBR (0.41) | CCKBRCCKAROXTRBDKRB1MME | |
| SCHEMBL12893383 | 0.86 | CCKBR (0.49) | CCKBRCCKARTRPA1BDKRB1 | |
| SCHEMBL8774054 | 0.85 | CCKBR (0.44) | CCKBRCCKAROXTRBDKRB1 | |
| SCHEMBL8774043 | 0.85 | CCKBR (0.44) | CCKBRCCKAROXTRBDKRB1 | |
| SCHEMBL9058638 | 0.84 | CCKBR (0.44) | CCKBRCCKAROXTRBDKRB1 | |
| SCHEMBL9058636 | 0.84 | CCKBR (0.44) | CCKBRCCKAROXTRBDKRB1 | |
| SCHEMBL8773971 | 0.84 | CCKBR (0.45) | CCKBRCCKARTRPA1BDKRB1 | |
| SCHEMBL8773965 | 0.84 | CCKBR (0.45) | CCKBRCCKARTRPA1BDKRB1 | |
| SCHEMBL9302353 | 0.83 | BDKRB1 (0.42) | CCKBRCCKARTRPA1BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4153310-B1 | BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS | F4 PHARMA GMBH (AT) | 2026-02-18 | — | — | EP | disclosed |
| CN-116348128-A | Bβ15-42 for treating viral endopdermatitis | F4医药有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-4153310-A1 | BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS | F4 Pharma GmbH (AT) | 2023-03-29 | — | — | EP | disclosed |